Your session is about to expire
← Back to Search
Self-Administered Web-Based Intervention for Depression and Anxiety
Study Summary
This trial is studying an affordable, accessible mental health intervention, Project Personality, to help reduce depression and anxiety in adolescents and young adults. #mentalhealth #mentalhealthintervention
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 13 and 24 years old.I am currently experiencing severe thoughts of harming myself or others, needing medical help.
- Group 1: Adolescent/Young Adult Self-Administered Web-Based Single-Session Intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants aged 55 and under eligible to partake in this experiment?
"The age parameters for successful enrolment into this medical trial are 13 and 24 years old, respectively."
Is my eligibility sufficient to enter this trial?
"The ideal participants for this trial are adolescent and young adult individuals with a diagnosis of anxiety, aged 13-24 years. It is estimated that 200 patients will be recruited overall."
Is there a possibility for new participants to join this clinical experiment?
"According to clinicaltrials.gov, this medical trial is no longer recruiting participants; the initial posting date was May 1st 2023 and the most recent update occured on April 21st of that same year. As an alternative, there are 1402 other studies actively enrolling patients at present."
What outcome is this investigation attempting to accomplish?
"The primary endpoint of this clinical trial, assessed pre-treatment and post 2 weeks and 2 months, is a shift in PROMIS (Patient Reported Outcomes Measurement Information System) Anxiety - Child. Secondary endpoints include the Perceived Secondary Control Scale, Acceptance and Action Questionnaire-II (AAQ-II), and Avoidance & Fusion Questionnaire for Youth 8 (AFQ-8). These ratings are scored on various scales from 0 to 4 or 1 to 7 depending on the question."
Share this study with friends
Copy Link
Messenger